Clinical Trial Update: Prostate Cancer Active Surveillance Metformin Trial [Phase 2]

View source ↗

Summary

A Phase 2 trial of metformin for active surveillance in prostate cancer has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• metformin (metformin)

Snippet

Sponsor: University Health Network, Toronto | Conditions: Prostate Cancer | Phase 2 | Status: WITHDRAWN